Standards; Pharmaceutical/API Drug Impurities/Metabolites;
XCC is an adenosine receptor antagonist.
Jacobson, K. A., et al.: Mol. Pharmacol., 29, 126 (1986); Thummler S., et al.: J. neurophysiol., 83, 1787 (2000); Soriano, A., et al.: J. Med. Chem., 52, 5590 (2009)